Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Pages
▼
Friday, April 10, 2015
. Earlier this month, the FDA’s Dallas District Office, upon assessment of the company’s corrective actions, notified Unique Pharmaceuticals in writing that it had “no objection to the company resuming sterile operations.”
No comments:
Post a Comment